Skip to main content

NHGRI to Fund Genomics Education, Career Development

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute will fund education programs and training initiatives that are connected to specific NHGRI initiatives or are aimed at spreading new information and approaches.

The institute will provide the education funding for two distinct types of programs. NHGRI will grant up to $50,000 per year for up to three years for courses that are short and advanced-level that spread new lab techniques, methods, and analysis that is related to the institute's mission.

The institute also will grant up to $300,000 per year for up to five years to fund research education and training initiatives that are linked to specific NHGRI initiatives, such as the Centers of Excellence in Genomic Science and large-scale sequencing and database grants.

NHGRI wants applicants for the Initiative to Maximize Research Education in Genomics program to design courses to cross-train genomics researchers, and it wants scholars involved in ethical, legal, and social implications of their research, in addition to courses in other areas. The focus should be on helping individuals transition to the next career level, remain in the sciences, pursue doctoral degrees or advanced training, and to pursue careers in genomics, said NIH.

These programs could include, but are not limited to, academic enhancement programs, career development activities, enhancements in writing scientific papers, and fellowship/grant applications, and developing scientific presentation and interviewing skills.

These courses should be targeted to those with doctoral level careers and beyond, and they should be hosted by academic or research institutions where the faculty is experienced in conducting training. They also should include established investigators or scholars in the area of instruction on the faculty, and they should be roughly two weeks in length and offered annually.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.